Your chances of a migraine increase with hotter temperatures
Research by Dr. Vincent Martin is featured in national and international media
A change in weather is one of the most common trigger factors for migraine. Hotter temperatures increase the chance of a migraine attack, according to research led by Vincent Martin, MD, director of the Headache and Facial Pain Center at UC’s Gardner Neuroscience Institute.
Martin, also a professor in the UC College of Medicine, spoke with Cincinnati’s Fox 19 News about his latest study findings which looked at use of Fremanezumab and whether it could prevent headaches caused by temperature increases. Produced by Teva Pharmaceuticals USA, Fremanezumab is sold under the brand name AJOVY®, administered by injection under the skin to treat migraines.
A research team led by Martin cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 10 degrees Fahrenheit daily, there was a 6% increase in occurrence of any headache. However, during the time periods of Fremanezumab treatment the association completely disappeared.
Record high temperatures across much of the Midwest and Northeast regions of the country has increased dialogue about health ailments associated with the heat. Martin’s findings were reported on more than 200 media outlets including CBS News, The Atlanta Journal Constitution, The Miami Herald and internationally in publications such as Greece’s Tempo 24, Argentina’s Infobae, Italy’s Agenzia Italia, Mexico’s El Cuarto Poder , Venezuela’s Noticias Venevision and Indonesia’s Suara Merdeka.
Read about the research findings from Vincent Martin, MD, online.
Learn more about migraines and hotter temperatures on CBS News
Featured top image is courtesy of Istock.
Related Stories
How the University of Cincinnati co-op program is shaping the future of work at SXSW
March 17, 2026
The University of Cincinnati served as a 2026 Workplace Track sponsor at the annual South by Southwest (SXSW) Innovation Conference March 12-18 in Austin, Texas, showcasing how co-op is redesigning the future of work.
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.